Literature DB >> 10488220

Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis.

F M Müller1, M Kasai, A Francesconi, B Brillante, M Roden, J Peter, S J Chanock, T J Walsh.   

Abstract

We report transmission of an azole-resistant, isogenic strain of Candida albicans in a human immunodeficiency virus (HIV)-infected family of two children with symptomatic oropharyngeal candidiasis and a mother with asymptomatic colonization over a 5-year period. These findings were confirmed by three different molecular epidemiology methods: interrepeat PCR, Southern hybridization with a C. albicans repetitive element 2 probe, and electrophoretic karyotyping. This study contributes to an evolving understanding of the mode of transmission of C. albicans, particularly in children, and underscores the importance of monitoring specimens from family members of HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488220      PMCID: PMC85585          DOI: 10.1128/JCM.37.10.3405-3408.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  Typing of Candida albicans strains.

Authors:  F C Odds; D L Brawner; J Staudinger; P T Magee; D R Soll
Journal:  J Med Vet Mycol       Date:  1992

Review 2.  Candida albicans strain delineation.

Authors:  W G Merz
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

Review 3.  The evolutionary biology and population genetics underlying fungal strain typing.

Authors:  J W Taylor; D M Geiser; A Burt; V Koufopanou
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 4.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

5.  [Molecular epidemiology of Candida infections in HIV-infected mothers and their offspring].

Authors:  M Ruhnke; I Grosch-Wörner; A Steinmüller; A Neubauer
Journal:  Wien Med Wochenschr       Date:  1997

6.  Isolation, characterization, and sequencing of Candida albicans repetitive element 2.

Authors:  B A Lasker; L S Page; T J Lott; G S Kobayashi
Journal:  Gene       Date:  1992-07-01       Impact factor: 3.688

Review 7.  Antifungal drug resistance in pathogenic fungi.

Authors:  H Vanden Bossche; F Dromer; I Improvisi; M Lozano-Chiu; J H Rex; D Sanglard
Journal:  Med Mycol       Date:  1998       Impact factor: 4.076

8.  Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients.

Authors:  A van Belkum; W Melchers; B E de Pauw; S Scherer; W Quint; J F Meis
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

9.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

Authors:  L Millon; A Manteaux; G Reboux; C Drobacheff; M Monod; T Barale; Y Michel-Briand
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.

Authors:  T M Diaz-Guerra; J V Martinez-Suarez; F Laguna; E Valencia; J L Rodriguez-Tudela
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

View more
  9 in total

1.  Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

Authors:  C P Girish Kumar; Ahmed Medhat Hanafy; Masakazu Katsu; Yuzuru Mikami; Thangam Menon
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

2.  PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions.

Authors:  K L Bartie; D W Williams; M J Wilson; A J Potts; M A Lewis
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.

Authors:  M Weig; F M Müller
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

4.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Authors:  E Roilides; E Farmaki; J Evdoridou; J Dotis; E Hatziioannidis; M Tsivitanidou; E Bibashi; I Filioti; D Sofianou; C Gil-Lamaignere; F-M Mueller; G Kremenopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

5.  Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients.

Authors:  Elaine Blignaut
Journal:  Mycopathologia       Date:  2007-02-12       Impact factor: 2.574

6.  Extensive chromosome rearrangements distinguish the karyotype of the hypovirulent species Candida dubliniensis from the virulent Candida albicans.

Authors:  B B Magee; Melissa D Sanchez; David Saunders; David Harris; M Berriman; P T Magee
Journal:  Fungal Genet Biol       Date:  2007-07-20       Impact factor: 3.495

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.

Authors:  Natalya U Makarova; V V Pokrowsky; A V Kravchenko; L V Serebrovskaya; Michael J James; Michael M McNeil; Brent A Lasker; David W Warnock; Errol Reiss
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Candidiasis during pregnancy may result from isogenic commensal strains.

Authors:  W Daniels; D D Glover; M Essmann; B Larsen
Journal:  Infect Dis Obstet Gynecol       Date:  2001
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.